-
HPA008453-100UL
ANTI-CDK7 ANTIBODY PRODUCED IN RABBIT (C15-1447-147)
Price: $977.14List Price: $1,085.71Immunogen cyclin dependent kinase 7 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the -
HPA006738-100UL
Anti-CDK9 antibody produced in rabbit
Price: $879.43List Price: $977.14Immunogen Cell division protein kinase 9 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are -
HPA059605-100UL
Anti-CDKL1 antibody produced in rabbit (C15-1463-327)
Price: $928.29List Price: $1,031.43Immunogen cyclin-dependent kinase-like 1 (CDC2-related kinase) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive -
HPA065919-100UL
Anti-CDKL1 antibody produced in rabbit (C15-1464-984)
Price: $928.29List Price: $1,031.43Immunogen cyclin-dependent kinase-like 1 (CDC2-related kinase) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive -
HPA040672-100UL
Anti-CDKL2 antibody produced in rabbit
Price: $928.29List Price: $1,031.43Immunogen cyclin-dependent kinase-like 2 (CDC2-related kinase) recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project -
HPA067895-100UL
Anti-CDKL4 antibody produced in rabbit
Price: $928.29List Price: $1,031.43Immunogen cyclin-dependent kinase-like 4 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in -
HPA005946-100UL
Anti-CDKN1A antibody produced in rabbit
Price: $879.43List Price: $977.14Immunogen cyclin-dependent kinase inhibitor 1A (p21, Cip1) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive -
HPA059086-100UL
Anti-CDKN1B antibody produced in rabbit
Price: $928.29List Price: $1,031.43Immunogen cyclin-dependent kinase inhibitor 1B (p27, Kip1) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive -
HPA002924-100UL
Anti-CDKN1C antibody produced in rabbit
Price: $879.43List Price: $977.14Immunogen Cyclin-dependent kinase inhibitor 1C recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, -
HPA047838-100UL
Anti-CDKN2A antibody produced in rabbit
Price: $928.29List Price: $1,031.43Immunogen cyclin-dependent kinase inhibitor 2A Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive -
HPA041397-100UL
Anti-CDKN2AIP antibody produced in rabbit (C15-1456-674)
Price: $928.29List Price: $1,031.43Immunogen CDKN2A interacting protein recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are -
HPA062142-100UL
Anti-CDKN2AIP antibody produced in rabbit (C15-1464-001)
Price: $928.29List Price: $1,031.43Immunogen CDKN2A interacting protein Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the